Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Hu, Shi Ling ^a   Zhao, Feng Rong ^b   Hu, Qin ^a   Chen, Wei Xian ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Department of Gynecology and Obstetrics Youyang People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN GP210; PROTEIN SP100; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; NUCLEOPORIN; SP100 PROTEIN, HUMAN;

ARTICLE; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; IMMUNOLOGY; LIVER CIRRHOSIS, BILIARY;

ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; AUTOANTIGENS; HUMANS; LIVER CIRRHOSIS, BILIARY; NUCLEAR PORE COMPLEX PROTEINS;

EID: 84904256991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101916     Document Type: Article

References (53)

1. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, et al. (2009) Primary biliary cirrhosis. Hepatology 50: 291-308. doi: 10.1002/hep.22906.
2. Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB (2008) Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis 12: 261-276; vii. doi: 10.1016/j.cld.2008.02.009.
3. Hu CJ, Zhang FC, Li YZ, Zhang X (2010) Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol 16: 3616-3629. doi:10.3748/wjg.v16.i29.3616.
4. Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman GL, et al. (2009) Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol 7: 1355-1360. doi: 10.1016/j.cgh.2009.07.012.
5. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, et al. (2005) Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 42: 386-392. doi: 10.1016/j.jhep.2004.11.016. (Pubitemid 40254254)
6. Xiao H, Chen JW, Xie X, Liu YM, Li F (2012) Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis. Beijing Da Xue Xue Bao 44: 209-214. doi: 10.3969/j.issn.1671-167X. 2012.02.010.
7. Shao J, Wei L, Wang H, Sun Y (2005) Detection of multicore point type antinuclear antibodies in primary biliary cirrhosis patients. World Chinese Journal of Digestology 13: 1478-1481.
8. Sternsdorf T, Guldner HH, Szostecki C, Grötzinger T, Will H (1995) Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42: 257-268. Doi: 10.1111/j.1365-3083.1995.tb03652.x.
9. Saito H, Takahashi A, Abe K, Okai K, Katsushima F, et al. (2012) Autoantibodies by line immunoassay in patients with primary biliary cirrhosis. Fukushima J Med Sci 58: 107-116. doi: org/10.5387/fms.58.107.
10. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, et al. (2003) Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 98: 431-437. doi:10.1111/j.1572-0241.2003. 07257.x. (Pubitemid 36232395)
11. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, et al. (2006) Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. HEPATOLOGY 43: 1135-1144. doi: 10.1002/hep.21172. (Pubitemid 43724638)
12. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, et al. (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45: 118-127. doi: 10.1002/hep.21472. (Pubitemid 46144371)
13. Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, et al. (1998) Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 13: 257-265. doi: 10.1111/j.1440-1746.1998.01553.x. (Pubitemid 28183956)
14. Tang YM, Bao WM, You LY, Jiang HJ, Yang JH (2011) Clinical significance of serum anti-SP100 and anti-GP210 detection in diagnosis of patients with primary biliary cirrhosis. J Clin Hepatol 14: 132-134. doi:10.3969/j.issn.1672- 5069.2011.02.018.
15. Lu JX, Qian SY (2011) Value of detection of autoantibody in differential diagnosis of chronic cholestatic liver disease. China Tropical Medicine 11: 1303-1304.
16. Liu Y, Yan HP, Tan YF, Zhang HP, Zhao Y, et al. (2009) Detection of anti-SP100 and nuclear dots antibodies in patients with primary biliary cirrhosis. Chines Journal of Clinical Laboratory Science 27: 256-258.
17. Peng WH, Tan LM, Chen JH, Li JM, Hu Y, et al. (2012) Study of specific autoantibodies in patients with primary biliary cirrhosis. Shandong Medical Journal 52: 17-19.
18. Stinton LM, Swain M, Myers RP, Shaheen AA, Fritzler MJ (2011) Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol 163: 147-156. doi: 10.1111/j.1365-2249.2010.04288.x.
19. Imura-Kumada S, Hasegawa M, Matsushita T, Hamaguchi Y, Encabo S, et al. (2012) High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol. 22: 892-898. doi: 10.1007/s10165-012-0607-z.
20. Hu C, Deng C, Song G, Zhang W, Zhang S, et al. (2011) Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci 56: 3357-3363. doi: 10.1007/s10620-011-1756-1.
21. Assassi S, Fritzler MJ, Arnett FC, Norman GL, Shah KR, et al. (2009) Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol. 36: 2250-2256. doi: 10.3899/jrheum.090340.
22. Du HH, Li QM, Zhou XZ, Liu Y, Wang LQ, et al. (2013) Diagnostic value of a variety of autoantibodies detection in patients with primary biliary cirrhosis. Chinese Journal of Liver Diseases 5: 19-23. doi: 10.3969/j.issn.1674- 7380.2013.01.004.
23. Wu J, Zeng KQ, Wang MJ, Jiang L, Guo YF, et al. (2012) Diagnostic value of gp210 and sp100 antibodies in patients with primary biliary cirrhosis. China Journal of Modern Medicine 22: 55-57.
24. Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, et al. (2003) Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis 35: 801-805. doi: 10.1016/S1590-8658(03)00466-3. (Pubitemid 41070511)
25. Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, et al. (2010) PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol 105: 125-131. doi: 10.1038/ajg.2009.596.
26. Tartakovsky F, Worman HJ (1995) Detection of Gp210 Autoantibodies in Primary Biliary Cirrhosis Using a Recombinant Protein Containing the Predominant Autoepitope. Hepatology 21: 495-500. doi: 10.1002/hep.1840210234.
27. Szostecki C, Guldner HH, Netter HJ, Will H (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145: 4338-4347. [PubMed, PMID: 2258622].
28. Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, et al. (1996) Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23: 1020-1024.doi: 10.1002/hep. 510230512. (Pubitemid 26137040)
29. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, et al. (1999) Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 19: 122-128. doi: 10.1111/j.1478-3231.1999.tb00021.x. (Pubitemid 29139765)
30. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E (1996) Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope. Hum Antibodies Hybridomas 7: 167-174. doi: 10.3233/HAB-1996-7404. (Pubitemid 27207867)
31. Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, et al. (2003) Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 20: 247-254. doi: org/10.1016/S0896-8411(03)00033-7.
32. Bauer A, Habior A (2007) Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J Clin Lab Anal 21: 227-231. doi: 10.1002/jcla.20170. (Pubitemid 47175022)
33. Gao L, Tian X, Liu B, Zhang F (2008) The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med 8: 9-15. doi: 10.1007/s10238-008- 0150-6. (Pubitemid 351666846)
34. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ (1994) Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106: 193-199. [PubMed, PMID: 8276182]. (Pubitemid 24011881)
35. Lozano F, Parés A, Borche L, Plana M, Gallart T, et al. (1988) Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 8: 930-938. doi: 10.1002/hep.1840080438.
36. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25. doi:10.1186/1471-2288-3-25.
37. Kumar Y, Bhatia A, Minz RW (2009) Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 4: 1. doi: 10.1186/1746-1596-4-1.
38. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 124: 71-81. doi: 10.1043/0003-9985(2000)124. (Pubitemid 30053777)
39. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, et al. (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117: 316-324. [PubMed, PMID: 11863229]. (Pubitemid 34823674)
40. Scagliusi P, De Lucia M, Di Luca ML, Pannarale M, Pipitone V (1984) Clinical significance of antinuclear antibodies in progressive systemic sclerosis. Minerva Med 75: 161-166. [PubMed, PMID: 6366619]. (Pubitemid 14185556)
41. Walker JG, Doniach D, Roitt IM, Sherlock S (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1: 827-831. [PubMed, PMID: 14263538].
42. Worman HJ, Courvalin JC (2003) Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2: 211-217. doi: 10.1016/S1568-9972(03) 00013-2. (Pubitemid 36793945)
43. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25: 298-310. doi: 10.1055/s-2005-916321. (Pubitemid 41254577)
44. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353: 1261-1273. doi: 10.1056/NEJMra043898. (Pubitemid 41345948)
45. Marasini B, Gagetta M, Rossi V, Ferrari P (2001) Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 60: 1046-1049. doi:10.1136/ard.60.11.1046. (Pubitemid 32989177)
46. Watt FE, James OF, Jones DE (2004) Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 97: 397-406. doi: 10.1093/qjmed/hch078. (Pubitemid 38967413)
47. Sakauchi F, Mori M, Zeniya M, Toda G (2005) A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 15: 24-28. doi: 10.2188/jea.15.24. (Pubitemid 41403867)
48. van de Water J, Cooper A, Surh CD, Coppel R, Danner D, et al. (1989) Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 320: 1377-1380. doi: 10.1056/NEJM198905253202104. (Pubitemid 19138932)
49. Hu SL, Zhao FR, Wang QS, Chen WX (2014) The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med. doi: 10.1515/cclm-2013- 0926. [Epub ahead of print].
50. Wozniak RW, Bartnik E, Blobel G (1989) Primary structure analysis of an integral membrane glycoprotein of the nuclear pore. J Cell Biol 108: 2083-2092. doi: 10.1083/jcb.108.6.2083. (Pubitemid 19168901)
51. Greber UF, Senior A, Gerace L (1990) A major glycoprotein of the nuclear pore complex is a membranespanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J 9: 1495-1502. [PubMed, PMID: 2184032].
52. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, et al. (2010) PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35: 436-442. doi: 10.1016/j.jaut.2010.09.005.
53. Zuchner D, Sternsdorf T, Szostecki C, Heathcote EJ, Cauch-Dudek K, et al. (1997) Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. HEPATOLOGY 26: 1123-1130. doi: 10.1002/hep.510260506. (Pubitemid 27509292)